Tirzapetide dose escalation schedules were slower in the real-world than clinical settings among individuals with obesity without T2D.

A novel investigational endoscopic procedure targeting the duodenum appears beneficial in improving glycemic parameters in ...

Ooops... Something went wrong while loading this page.

As summer approaches, millions of Americans are turning to weight-loss injections in hopes of shedding pounds—fast. Roughly ...

Shares of Eli Lilly (NYSE: LLY) sank after the drugmaker lowered its full-year profit outlook, and a potential headwind to ...

With more and more people signing up for weight loss drugs, the potential side effects are starting to attract attention. Helen Coffey speaks to the dentists warning that jabs could have a worrying im ...

TOPPING the scales at 16 stone, Joann Burland knew something had to change. At 5ft 2in and a size 20, the 49-year-old from ...

Obesity is a global pandemic. According to the World Health Organization (WHO), adult obesity in the world more than doubled ...

Lilly now plans to file for approval to add the heart failure indication to the label for tirzepatide, which is already sold as Mounjaro for type 2 diabetes and Zepbound for obesity, later this year.

Physicians describe common prior authorization challenges when treating patients for obesity and share strategies to overcome ...

The celebrated actress has lost more than 100Ib after turning to controversial diabetes jab Ozempic - now better known for ...

Metamorphx is emerging as a leading natural GLP-1 alternative for weight loss in 2025. With prescription options like ...